Cleerly LABS vs Aorta-CAD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by Imagen Technologies

AI Verdict

Cleerly LABS and Aorta-CAD are adjacent tools within cardiovascular imaging AI, but they are not direct competitors. Cleerly LABS focuses on comprehensive analysis of coronary CT angiography (CCTA) for detailed assessment of coronary atherosclerosis and stenosis. In contrast, Aorta-CAD assists in detecting signs of aortic atherosclerosis and ectasia on chest X-rays, serving a different diagnostic workflow and anatomical focus.

Choose Cleerly LABS if…

Choose Cleerly LABS if you require a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely quantify and characterize atherosclerosis and stenosis. This tool is ideal for detailed personalized heart disease management, including tracking disease progression and assessing specific plaque burden, when CCTA imaging is already available or indicated.

View Cleerly LABS →

Choose Aorta-CAD if…

Choose Aorta-CAD if you need AI assistance for the rapid and accurate detection of potential Aortic Atherosclerosis and Aortic Ectasia directly from routine chest X-rays. This tool is best suited for enhancing the interpretation of frontline diagnostic imaging in high-volume settings, aiding both radiologists and primary care physicians in identifying early signs of aortic conditions.

View Aorta-CAD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS Aorta-CAD
Pricing Varies Unknown
Deployment Cloud, On-premise Cloud-based software that integrates into existing chest X-ray workflows and Picture Archiving and Communication System (PACS) viewers.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Aorta-CAD

Aorta-CAD emphasizes seamless integration into existing X-ray reading workflows and provides annotations as an overlay that can be toggled on/off, suggesting minimal disruption and ease of use for physicians. Cleerly LABS, while web-based and offering 3D visualization, involves a more comprehensive analysis of CCTA, which may require a more dedicated workflow.

Clinical Value

Cleerly LABS

Cleerly LABS offers a comprehensive and personalized approach to heart disease management by quantifying and characterizing coronary plaque and stenosis, and tracking disease progression over time. While Aorta-CAD improves detection rates for specific aortic conditions on chest X-rays, Cleerly's detailed CCTA analysis provides deeper insights for personalized treatment and long-term patient care.

Pricing & Value

Cleerly LABS

Cleerly LABS provides transparent pricing information, including a retail price and a discounted offer, even though the total cost can be significant. Aorta-CAD's pricing is only available upon contact, making it difficult for potential customers to assess its value without direct engagement.

Enterprise Readiness

Cleerly LABS

Both tools are FDA-cleared, HIPAA compliant, and cloud-based with BAAs. However, Cleerly LABS explicitly mentions integration with PACS, RIS, and EHR via an on-site Cleerly Proxy for data transfer, indicating a more robust and defined strategy for integration within complex enterprise healthcare IT environments.

Innovation

Cleerly LABS

Cleerly LABS focuses on creating a new standard of care by providing comprehensive, quantitative plaque assessment and tracking disease progression from CCTA, aiming to eliminate heart attacks through AI-powered cardiovascular imaging. Aorta-CAD, while valuable in improving detection on chest X-rays, represents an enhancement to existing diagnostic workflows rather than a fundamental shift in disease management.

Support & Docs

Cleerly LABS

Cleerly provides a dedicated 'Support' section on its website with contact forms, email support, FAQs, and resources for clinicians and patients, including billing guidelines and webinars. Imagen Technologies also offers support, including a contact form and mention of customer success teams, but Cleerly's online resources appear more extensive and readily accessible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS Aorta-CAD
Tool Name Cleerly LABS Aorta-CAD
Company Cleerly Imagen Technologies
Primary Imaging Modality Coronary CT Angiography (CCTA) Chest X-rays
Conditions Detected Atherosclerosis, stenosis, coronary plaque (volume, type), ischemia (with Cleerly ISCHEMIA module), disease progression. Aortic Atherosclerosis, Aortic Ectasia
Key Technology AI-powered CCTA image analysis, comprehensive coronary plaque assessment, 3D visualization. AI software, deep learning algorithms, detects and highlights radiographic findings.
Integration Integration with PACS, RIS, EHR via Cleerly Proxy. Seamlessly integrates into existing X-ray reading workflows.

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and Aorta-CAD.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is designed for comprehensive analysis of coronary CT angiography (CCTA) images. In contrast, Aorta-CAD by Imagen Technologies assists physicians in detecting findings on chest X-rays.
Cleerly LABS detects, quantifies, and characterizes atherosclerosis and stenosis in coronary arteries, and can detect ischemia with its ISCHEMIA module. Aorta-CAD helps physicians detect signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays.
Cleerly LABS aims to aid in personalized heart disease management, risk assessment, and tracking disease progression over time through detailed CCTA analysis. Aorta-CAD has demonstrated a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta in clinical studies.
Cleerly LABS is primarily intended for Cardiology and Radiology specialties. Aorta-CAD is designed to assist physicians across Cardiology, Internal Medicine, and Radiology in interpreting chest X-rays.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.